Quantitative estimate of the risk of blood donation contamination by infectious agents;Estimation quantitative du risque de contamination d'un don de sang par des agents infectieux

Transfusion Clinique et Biologique

Volumn 16, Issue 2, 2009, Pages 138-145

  Pillonel, J ^a   Brouard, C ^a   Laperche, S ^b   Barin, F ^c,d,e   Bernillon, P ^a   de Valk, H ^a  

^a INSTITUT DE VEILLE SANITAIRE   (France)

^b INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

^c UNIVERSITÉ DE TOURS   (France)

^d INSERM   (France)

^e Centre national de référence   (France)

Author keywords

Blood transfusion; Infectious agents; Risk assessment

Indexed keywords

BLOOD DONOR; BLOOD TRANSFUSION; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS; HUMAN T CELL LEUKEMIA VIRUS INFECTION; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; NONHUMAN; RISK ASSESSMENT; SHORT SURVEY; VIRAL CONTAMINATION; VIRUS TRANSMISSION;

BLOOD; BLOOD DONORS; BLOOD TRANSFUSION; BLOOD-BORNE PATHOGENS; DISEASE TRANSMISSION, INFECTIOUS; HUMANS; RISK; VIRUS DISEASES;

EID: 67349171604     PISSN: 12467820     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tracli.2009.03.016     Document Type: Short Survey

References (19)

1. Pillonel J., Laperche S., and pour le comité de pilotage pour la surveillance épidémiologique des donneurs de sang. Surveillance épidémiologique des donneurs de sang homologues et risque résiduel en France entre 2003 et 2005. BEH (2006) 411-414
2. Pillonel J., and Laperche S. Trends in risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2003 and impact of nucleic acid testing (NAT). Euro Surveill 10 (2005) 5-8
3. Brouard C., De Valk H., Pillonel J., Assal A., Bernillon P., Biagini P., et al. Estimation quantitative du risque de contamination d'un don de sang par des agents infectieux (2007), Rapport Institut de veille sanitaire, Saint-Maurice
4. Schreiber G.B., Busch M.P., Kleinman S.H., and Korelitz J.J. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 334 (1996) 1685-1690
5. Busch M.P. Closing the windows on viral transmission by blood transfusion. In: Stamer S.L. (Ed). Blood Safety in the New Millenium (2001), American Association of Blood Banks 33-54
6. Manns A., Wilks R.J., Hanchard B., Morgan O.S., Rudolph D.L., and Lal R.B. Viral-specific humoral immune responses following transfusion-related transmission of human T cell lymphotropic virus type-I infection. Viral Immunol 7 (1994) 113-120
7. Kleinman S.H., and Busch M.P. Assessing the impact of HBV NAT on window period reduction and residual risk. J Clin Virol 36 Suppl. 1 (2006) S23-S29
8. Pillonel J., Barin F., Laperche S., Bernillon P., Le V.S., Brunet S., et al. Human immunodeficiency virus type 1 incidence among blood donors in France, 1992 through 2006: use of an immunoassay to identify recent infections. Transfusion 48 (2008) 1567-1575
9. Barin F., Meyer L., Lancar R., Deveau C., Gharib M., Laporte A., et al. Development and validation of an immunoassay for identification of recent human immunodeficiency virus type 1 infections and its use on dried serum spots. J Clin Microbiol 43 (2005) 4441-4447
10. Janssen R.S., Satten G.A., Stramer S.L., Rawal B.D., O'Brien T.R., Weiblen B.J., et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA 280 (1998) 42-48
11. Biggerstaff B.J., and Petersen L.R. Estimated risk of transmission of the West Nile virus through blood transfusion in the US, 2002. Transfusion 43 (2003) 1007-1017
12. Biggerstaff B.J., and Petersen L.R. Estimated risk of West Nile virus transmission through blood transfusion during an epidemic in Queens, New York City. Transfusion 42 (2002) 1019-1026
13. Tambyah P.A., Koay E.S., Poon M.L., Lin R.V., and Ong B.K. Dengue hemorrhagic fever transmitted by blood transfusion. N Engl J Med 359 (2008) 1526-1527
14. Brouard C., Bernillon P., Quatresous I., Pillonel J., Assal A., De V.H., et al. Estimated risk of Chikungunya viremic blood donation during an epidemic on Reunion Island in the Indian Ocean, 2005 to 2007. Transfusion 48 (2008) 1333-1341
15. Le Pont F., Costagliola D., Rouzioux C., and Valleron A.J. How much would the safety of blood transfusion be improved by including p24 antigen in the battery of tests?. Transfusion 35 (1995) 542-547
16. Petersen L.R., Satten G.A., Dodd R., Busch M., Kleinman S., Grindon A., et al. Duration of time from onset of human immunodeficiency virus type 1 infectiousness to development of detectable antibody. Transfusion 34 (1994) 283-289
17. Pillonel J., and Laperche S. Trends in residual risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2002 and impact of Nucleic Acid Testing. Transfus Clin Biol 11 (2004) 81-86
18. Denis F., Abitbol V., and Aufrere A. Evolution of strategy and coverage rates for hepatitis B vaccination in France, a country with low endemicity. Med Mal Infect 34 (2004) 149-158
19. Hladik W., Dollard S.C., Mermin J., Fowlkes A.L., Downing R., Amin M.M., et al. Transmission of human herpesvirus 8 by blood transfusion. N Engl J Med 355 (2006) 1331-1338